nifedipine has been researched along with prednisolone in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (5.26) | 18.7374 |
1990's | 6 (15.79) | 18.2507 |
2000's | 16 (42.11) | 29.6817 |
2010's | 13 (34.21) | 24.3611 |
2020's | 1 (2.63) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Abraham, MH; Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
al-Waili, NS | 1 |
Healy, MJ; Lennard-Jones, JE; MacRae, KD; Parkins, RA; Powell-Tuck, J | 1 |
Barton, C; Beer, JC; Dawnay, A; Marsh, FP; Raftery, MJ; Wilkie, ME | 1 |
Bell, PR; Feehally, J; Kehinde, EO; Nicholson, ML; Veitch, PS; Wheatley, T | 1 |
Fassihi, R; Kim, H | 1 |
Ashley, FP; Koffman, CG; Morel, A; Ogg, CS; Rigden, SP; Smith, D; Wilson, RF | 1 |
Beaman, M; D'Souza, RJ; Hamilton-Wood, C; Nicholls, AJ; Pearson, ER | 1 |
Knuuttila, ML; Nurmenniemi, PK; Pernu, HE | 2 |
Koski, T; Vilpo, J; Vilpo, L | 1 |
Baboolal, K; Newcombe, RG; Subramanian, N; Thomas, DW | 1 |
Furness, PN; Murphy, GJ; Nicholson, ML; Sandford, RS; Waller, JR | 1 |
Bonaccorsi, A; Condorelli, SV; Marchese, F; Motta, M; Saita, A | 1 |
Girndt, M; Herink, AK; Keysser, G; Köthe, L | 1 |
Katayama, A; Makino, H; Matsumoto, Y; Nasu, Y; Otsuka, F; Tanabe, K; Tsukamoto, N; Yamanaka, R | 1 |
Adeneye, AA; Akindele, AJ; Benebo, AS; Olatoye, F | 1 |
Itolikar, M; Itolikar, SM; Phatak, S; Salagre, S | 1 |
Enoki, Y; Hitomi, M; Inoue, N; Kawabata, H; Kawakatsu, Y; Minamikawa, T; Miyata, M; Motoi, S; Okazaki, Y; Sone, D; Ueda, Y; Yamaguchi, K | 1 |
1 review(s) available for nifedipine and prednisolone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 trial(s) available for nifedipine and prednisolone
Article | Year |
---|---|
Nifedipine in corticosteroid-dependent asthma: preliminary study.
Topics: Adrenal Cortex Hormones; Adult; Aged; Asthma; Blood Pressure; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Nifedipine; Peak Expiratory Flow Rate; Prednisolone; Randomized Controlled Trials as Topic; Substance-Related Disorders | 1989 |
A defence of the small clinical trial: evaluation of three gastroenterological studies.
Topics: Adult; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Colonic Diseases, Functional; Enema; Evaluation Studies as Topic; Humans; Mesalamine; Middle Aged; Nifedipine; Pain; Prednisolone; Sampling Studies | 1986 |
Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients.
Topics: Adult; Azathioprine; Blood Pressure; Creatinine; Cyclosporine; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Nifedipine; Prednisolone; Proteinuria; Regional Blood Flow; Renal Circulation; Time Factors; Transplantation, Homologous; Vascular Resistance | 1993 |
Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
Topics: Aged; Azathioprine; Cadaver; Calcium Channel Blockers; Costs and Cost Analysis; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Muromonab-CD3; Nifedipine; Prednisolone; Time Factors; Tissue Donors; United States | 1996 |
Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis.
Topics: Adult; Analysis of Variance; Aspirin; Cyclosporine; Extracellular Matrix; Female; Fibrosis; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Nifedipine; Prednisolone; Prospective Studies; Tacrolimus; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2003 |
32 other study(ies) available for nifedipine and prednisolone
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogPoct: a tool for lipophilicity determination in drug discovery.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Solvents | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics.
Topics: Delayed-Action Preparations; Diltiazem; Kinetics; Lactose; Methylcellulose; Molecular Weight; Nifedipine; Oxazines; Pectins; Prednisolone; Pressure; Solubility; Tablets; Theophylline | 1997 |
Contribution of individual drugs to gingival overgrowth in adult and juvenile renal transplant patients treated with multiple therapy.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Azathioprine; Body Weight; Calcium Channel Blockers; Child; Child, Preschool; Cyclosporine; Dental Plaque; Drug Combinations; Female; Gingival Overgrowth; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation; Lip; Logistic Models; Male; Middle Aged; Mouth Breathing; Nifedipine; Prednisolone; Time Factors | 1998 |
Hypertensive encephalopathy and nephrotic syndrome: a possible link?
Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Azathioprine; Brain Diseases; Calcium Channel Blockers; Diuretics; Doxazosin; Female; Furosemide; Headache; Humans; Hypertension; Immunosuppressive Agents; Magnetic Resonance Imaging; Middle Aged; Nephrotic Syndrome; Nifedipine; Prednisolone; Seizures; Visual Acuity | 1999 |
Density of CD1a-labeled Langerhans' cells in normal human gingiva and in nifedipine- and immunosuppressive medication-induced gingival overgrowth.
Topics: Adult; Anti-Inflammatory Agents; Antigens, CD1; Azathioprine; Calcium Channel Blockers; Cell Count; Connective Tissue; Cyclosporine; Epithelial Attachment; Epithelium; Female; Gingiva; Gingival Overgrowth; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Kidney Transplantation; Langerhans Cells; Male; Nifedipine; Prednisolone | 1999 |
Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
Topics: Adult; Aged; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; B-Lymphocytes; Calcium; Calcium Channel Blockers; Calcium Signaling; Chlorambucil; Cisplatin; Cladribine; Cyclosporine; DNA Fragmentation; Doxorubicin; Drug Synergism; Female; Flow Cytometry; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nifedipine; Prednisolone; Tumor Cells, Cultured; Verapamil; Vidarabine; Vincristine | 2000 |
Mitotic activity of keratinocytes in nifedipine- and immunosuppressive medication-induced gingival overgrowth.
Topics: Adult; Aged; Azathioprine; Calcium Channel Blockers; Cell Count; Cyclosporine; Epithelial Cells; Epithelium; Female; Gingiva; Gingival Overgrowth; Glucocorticoids; Heart Diseases; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Keratinocytes; Ki-67 Antigen; Male; Middle Aged; Mitosis; Nifedipine; Organ Transplantation; Prednisolone; Statistics as Topic; Statistics, Nonparametric | 2001 |
Cyclosporin A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients.
Topics: Adolescent; Adult; Aged; Azathioprine; Calcium Channel Blockers; Child; Child, Preschool; Creatinine; Cyclosporine; Dental Plaque; Emulsions; Female; Gingival Hyperplasia; Gingivitis; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Nifedipine; Prednisolone; Regression Analysis; Risk Factors; Transplantation, Homologous | 2001 |
Our experience with nifedipine and prednisolone as expulsive therapy for ureteral stones.
Topics: Administration, Oral; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Nifedipine; Prednisolone; Prospective Studies; Radiography; Risk Assessment; Severity of Illness Index; Treatment Outcome; Ureteral Calculi | 2004 |
[Treatment options of acral ulcers in MCTD].
Topics: Adult; Amides; Analgesia, Patient-Controlled; Angiography, Digital Subtraction; Autonomic Nerve Block; Azathioprine; Combined Modality Therapy; Drug Therapy, Combination; Female; Fingers; Humans; Hyperbaric Oxygenation; Iloprost; Infusions, Intravenous; Mixed Connective Tissue Disease; Nifedipine; Prednisolone; Raynaud Disease; Ropivacaine; Skin Ulcer; Vasodilator Agents | 2010 |
Unexpected occurrence of adrenal Cushing's syndrome in a patient with systemic lupus erythematosus.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Angiomyolipoma; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cushing Syndrome; Drug Therapy, Combination; Female; Humans; Hypertension; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Nifedipine; Prednisolone; Ribonucleosides; Spironolactone; Tetrazoles | 2011 |
Protective effect of selected calcium channel blockers and prednisolone, a phospholipase-A2 inhibitor, against gentamicin and carbon tetrachloride-induced nephrotoxicity.
Topics: Animals; Antioxidants; Biomarkers; Calcium Channel Blockers; Carbon Tetrachloride; Cytoprotection; Diltiazem; Disease Models, Animal; Gentamicins; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Nifedipine; Oxidative Stress; Phospholipase A2 Inhibitors; Prednisolone; Rats, Wistar; Time Factors; Verapamil | 2014 |
Recurrent cardiac tamponade in a young woman.
Topics: Adult; Cardiac Tamponade; Cardiomegaly; Cyclophosphamide; Female; Humans; Hypothyroidism; Nifedipine; Pericardial Effusion; Pericardium; Prednisolone; Scleroderma, Systemic; Tomography, X-Ray Computed | 2013 |
IgG4-related Autoimmune Hepatitis with a Suspected Drug-induced Etiology.
Topics: Aged; Anti-Inflammatory Agents; Cholagogues and Choleretics; Hepatitis, Autoimmune; Hepatitis, Chronic; Humans; Immunoglobulin G; Japan; Male; Nifedipine; Prednisolone; Treatment Outcome; Ursodeoxycholic Acid | 2020 |